Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Single Pill Combination (Amlodipine/Valsartan) in Hypertensive Patients Not Controlled on Previous Monotherapy: An Observational Real Life Study

NCT03371797 is registered in ClinicalTrials.gov with PharmEvo Pvt Ltd as lead sponsor.

NCT NCT03371797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03371797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Single Pill Combination (Amlodipine/Valsartan) in Hypertensive Patients Not Controlled on Previous Monotherapy: An Observational Real Life Study
Lead sponsor
PharmEvo Pvt Ltd
Phase
Observational
Overall status
Completed
Start date
February 20, 2018
Completion date
November 5, 2018
Enrollment
800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension